Global Ponatinib Drugs Market Research Report 2024

Industry: Pharma & Healthcare

Published: 2024-01-16

Pages: 69 Pages

Report ld: 2256941

Request Sample

Pre-Order Enquiry

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description

Ponatinib Drugs is an oral drug developed by ARIAD Pharmaceuticalsfor the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome–positive (Ph+) acute lymphoblastic leukemia(ALL).

The global Ponatinib Drugs market was valued at US$ 592 million in 2023 and is anticipated to reach US$ 902.8 million by 2030, witnessing a CAGR of 6.4% during the forecast period 2024-2030.

Ponatinib Drugs Market Size(US$)

M= millions and B=billions

For many patients with CML or Ph+ ALL, ponatinib became a long-term treatment to manage their condition effectively. This sustained demand was driven by the need for ongoing therapy to control cancer progression.

Ongoing clinical trials and research exploring the use of ponatinib in different settings, combinations, or other types of cancer may have increased interest and demand for the drug.

This report aims to provide a comprehensive presentation of the global market for Ponatinib Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ponatinib Drugs.

Report Scope
The Ponatinib Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Ponatinib Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Ponatinib Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Report Metric
Details
Report Title
Global Ponatinib Drugs Market Research Report 2024
Forecasted Market Size in 2030
US$ 902.8 million
CAGR(2024-2030)
6.4%
Market Size Available for Years
2024-2030
Global Ponatinib Drugs Companies Covered
ARIAD Pharmaceuticals
Global Ponatinib Drugs Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Ponatinib Drugs Market, Segment by Type
45mg
15mg
Global Ponatinib Drugs Market, Segment by Application
CML
ALL
Forecast Units
Million USD
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Ponatinib Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Ponatinib Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Table of Contents

1 Ponatinib Drugs Market Overview
    1.1 Product Overview and Scope of Ponatinib Drugs
    1.2 Ponatinib Drugs Segment by Type
        1.2.1 Global Ponatinib Drugs Market Value Comparison by Type (2024-2030)
        1.2.2 45mg
        1.2.3 15mg
    1.3 Ponatinib Drugs Segment by Application
        1.3.1 Global Ponatinib Drugs Market Value by Application: (2024-2030)
        1.3.2 CML
        1.3.3 ALL
    1.4 Global Ponatinib Drugs Market Size Estimates and Forecasts
        1.4.1 Global Ponatinib Drugs Revenue 2019-2030
        1.4.2 Global Ponatinib Drugs Sales 2019-2030
        1.4.3 Global Ponatinib Drugs Market Average Price (2019-2030)
    1.5 Assumptions and Limitations

2 Ponatinib Drugs Market Competition by Manufacturers
    2.1 Global Ponatinib Drugs Sales Market Share by Manufacturers (2019-2024)
    2.2 Global Ponatinib Drugs Revenue Market Share by Manufacturers (2019-2024)
    2.3 Global Ponatinib Drugs Average Price by Manufacturers (2019-2024)
    2.4 Global Ponatinib Drugs Industry Ranking 2022 VS 2023 VS 2024
    2.5 Global Key Manufacturers of Ponatinib Drugs, Manufacturing Sites & Headquarters
    2.6 Global Key Manufacturers of Ponatinib Drugs, Product Type & Application
    2.7 Ponatinib Drugs Market Competitive Situation and Trends
        2.7.1 Ponatinib Drugs Market Concentration Rate
        2.7.2 The Global Top 5 and Top 10 Largest Ponatinib Drugs Players Market Share by Revenue
        2.7.3 Global Ponatinib Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Ponatinib Drugs Retrospective Market Scenario by Region
    3.1 Global Ponatinib Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
    3.2 Global Ponatinib Drugs Global Ponatinib Drugs Sales by Region: 2019-2030
        3.2.1 Global Ponatinib Drugs Sales by Region: 2019-2024
        3.2.2 Global Ponatinib Drugs Sales by Region: 2025-2030
    3.3 Global Ponatinib Drugs Global Ponatinib Drugs Revenue by Region: 2019-2030
        3.3.1 Global Ponatinib Drugs Revenue by Region: 2019-2024
        3.3.2 Global Ponatinib Drugs Revenue by Region: 2025-2030
    3.4 North America Ponatinib Drugs Market Facts & Figures by Country
        3.4.1 North America Ponatinib Drugs Market Size by Country: 2019 VS 2023 VS 2030
        3.4.2 North America Ponatinib Drugs Sales by Country (2019-2030)
        3.4.3 North America Ponatinib Drugs Revenue by Country (2019-2030)
        3.4.4 U.S.
        3.4.5 Canada
    3.5 Europe Ponatinib Drugs Market Facts & Figures by Country
        3.5.1 Europe Ponatinib Drugs Market Size by Country: 2019 VS 2023 VS 2030
        3.5.2 Europe Ponatinib Drugs Sales by Country (2019-2030)
        3.5.3 Europe Ponatinib Drugs Revenue by Country (2019-2030)
        3.5.4 Germany
        3.5.5 France
        3.5.6 U.K.
        3.5.7 Italy
        3.5.8 Russia
    3.6 Asia Pacific Ponatinib Drugs Market Facts & Figures by Country
        3.6.1 Asia Pacific Ponatinib Drugs Market Size by Country: 2019 VS 2023 VS 2030
        3.6.2 Asia Pacific Ponatinib Drugs Sales by Country (2019-2030)
        3.6.3 Asia Pacific Ponatinib Drugs Revenue by Country (2019-2030)
        3.6.4 China
        3.6.5 Japan
        3.6.6 South Korea
        3.6.7 India
        3.6.8 Australia
        3.6.9 Taiwan
        3.6.10 Indonesia
        3.6.11 Thailand
        3.6.12 Malaysia
        3.6.13 Philippines
    3.7 Latin America Ponatinib Drugs Market Facts & Figures by Country
        3.7.1 Latin America Ponatinib Drugs Market Size by Country: 2019 VS 2023 VS 2030
        3.7.2 Latin America Ponatinib Drugs Sales by Country (2019-2030)
        3.7.3 Latin America Ponatinib Drugs Revenue by Country (2019-2030)
        3.7.4 Mexico
        3.7.5 Brazil
        3.7.6 Argentina
    3.8 Middle East and Africa Ponatinib Drugs Market Facts & Figures by Country
        3.8.1 Middle East and Africa Ponatinib Drugs Market Size by Country: 2019 VS 2023 VS 2030
        3.8.2 Middle East and Africa Ponatinib Drugs Sales by Country (2019-2030)
        3.8.3 Middle East and Africa Ponatinib Drugs Revenue by Country (2019-2030)
        3.8.4 Turkey
        3.8.5 Saudi Arabia
        3.8.6 UAE

4 Segment by Type
    4.1 Global Ponatinib Drugs Sales by Type (2019-2030)
        4.1.1 Global Ponatinib Drugs Sales by Type (2019-2024)
        4.1.2 Global Ponatinib Drugs Sales by Type (2025-2030)
        4.1.3 Global Ponatinib Drugs Sales Market Share by Type (2019-2030)
    4.2 Global Ponatinib Drugs Revenue by Type (2019-2030)
        4.2.1 Global Ponatinib Drugs Revenue by Type (2019-2024)
        4.2.2 Global Ponatinib Drugs Revenue by Type (2025-2030)
        4.2.3 Global Ponatinib Drugs Revenue Market Share by Type (2019-2030)
    4.3 Global Ponatinib Drugs Price by Type (2019-2030)

5 Segment by Application
    5.1 Global Ponatinib Drugs Sales by Application (2019-2030)
        5.1.1 Global Ponatinib Drugs Sales by Application (2019-2024)
        5.1.2 Global Ponatinib Drugs Sales by Application (2025-2030)
        5.1.3 Global Ponatinib Drugs Sales Market Share by Application (2019-2030)
    5.2 Global Ponatinib Drugs Revenue by Application (2019-2030)
        5.2.1 Global Ponatinib Drugs Revenue by Application (2019-2024)
        5.2.2 Global Ponatinib Drugs Revenue by Application (2025-2030)
        5.2.3 Global Ponatinib Drugs Revenue Market Share by Application (2019-2030)
    5.3 Global Ponatinib Drugs Price by Application (2019-2030)

6 Key Companies Profiled
    6.1 ARIAD Pharmaceuticals
        6.1.1 ARIAD Pharmaceuticals Corporation Information
        6.1.2 ARIAD Pharmaceuticals Description and Business Overview
        6.1.3 ARIAD Pharmaceuticals Ponatinib Drugs Sales, Revenue and Gross Margin (2019-2024)
        6.1.4 ARIAD Pharmaceuticals Ponatinib Drugs Product Portfolio
        6.1.5 ARIAD Pharmaceuticals Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis
    7.1 Ponatinib Drugs Industry Chain Analysis
    7.2 Ponatinib Drugs Key Raw Materials
        7.2.1 Key Raw Materials
        7.2.2 Raw Materials Key Suppliers
    7.3 Ponatinib Drugs Production Mode & Process
    7.4 Ponatinib Drugs Sales and Marketing
        7.4.1 Ponatinib Drugs Sales Channels
        7.4.2 Ponatinib Drugs Distributors
    7.5 Ponatinib Drugs Customers

8 Ponatinib Drugs Market Dynamics
    8.1 Ponatinib Drugs Industry Trends
    8.2 Ponatinib Drugs Market Drivers
    8.3 Ponatinib Drugs Market Challenges
    8.4 Ponatinib Drugs Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source
    10.1 Methodology/Research Approach
        10.1.1 Research Programs/Design
        10.1.2 Market Size Estimation
        10.1.3 Market Breakdown and Data Triangulation
    10.2 Data Source
        10.2.1 Secondary Sources
        10.2.2 Primary Sources
    10.3 Author List
    10.4 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Ponatinib Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Ponatinib Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Ponatinib Drugs Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Ponatinib Drugs Sales (K Units) of Key Manufacturers (2019-2024)
    Table 5. Global Ponatinib Drugs Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Ponatinib Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Ponatinib Drugs Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Ponatinib Drugs Average Price (USD/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Ponatinib Drugs, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Ponatinib Drugs, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Ponatinib Drugs, Product Type & Application
    Table 12. Global Key Manufacturers of Ponatinib Drugs, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Ponatinib Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ponatinib Drugs as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Ponatinib Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Ponatinib Drugs Sales by Region (2019-2024) & (K Units)
    Table 18. Global Ponatinib Drugs Sales Market Share by Region (2019-2024)
    Table 19. Global Ponatinib Drugs Sales by Region (2025-2030) & (K Units)
    Table 20. Global Ponatinib Drugs Sales Market Share by Region (2025-2030)
    Table 21. Global Ponatinib Drugs Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Ponatinib Drugs Revenue Market Share by Region (2019-2024)
    Table 23. Global Ponatinib Drugs Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Ponatinib Drugs Revenue Market Share by Region (2025-2030)
    Table 25. North America Ponatinib Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Ponatinib Drugs Sales by Country (2019-2024) & (K Units)
    Table 27. North America Ponatinib Drugs Sales by Country (2025-2030) & (K Units)
    Table 28. North America Ponatinib Drugs Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Ponatinib Drugs Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Ponatinib Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Ponatinib Drugs Sales by Country (2019-2024) & (K Units)
    Table 32. Europe Ponatinib Drugs Sales by Country (2025-2030) & (K Units)
    Table 33. Europe Ponatinib Drugs Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Ponatinib Drugs Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Ponatinib Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Ponatinib Drugs Sales by Region (2019-2024) & (K Units)
    Table 37. Asia Pacific Ponatinib Drugs Sales by Region (2025-2030) & (K Units)
    Table 38. Asia Pacific Ponatinib Drugs Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Ponatinib Drugs Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Ponatinib Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Ponatinib Drugs Sales by Country (2019-2024) & (K Units)
    Table 42. Latin America Ponatinib Drugs Sales by Country (2025-2030) & (K Units)
    Table 43. Latin America Ponatinib Drugs Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Ponatinib Drugs Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Ponatinib Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Ponatinib Drugs Sales by Country (2019-2024) & (K Units)
    Table 47. Middle East & Africa Ponatinib Drugs Sales by Country (2025-2030) & (K Units)
    Table 48. Middle East & Africa Ponatinib Drugs Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Ponatinib Drugs Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Ponatinib Drugs Sales (K Units) by Type (2019-2024)
    Table 51. Global Ponatinib Drugs Sales (K Units) by Type (2025-2030)
    Table 52. Global Ponatinib Drugs Sales Market Share by Type (2019-2024)
    Table 53. Global Ponatinib Drugs Sales Market Share by Type (2025-2030)
    Table 54. Global Ponatinib Drugs Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Ponatinib Drugs Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Ponatinib Drugs Revenue Market Share by Type (2019-2024)
    Table 57. Global Ponatinib Drugs Revenue Market Share by Type (2025-2030)
    Table 58. Global Ponatinib Drugs Price (USD/Unit) by Type (2019-2024)
    Table 59. Global Ponatinib Drugs Price (USD/Unit) by Type (2025-2030)
    Table 60. Global Ponatinib Drugs Sales (K Units) by Application (2019-2024)
    Table 61. Global Ponatinib Drugs Sales (K Units) by Application (2025-2030)
    Table 62. Global Ponatinib Drugs Sales Market Share by Application (2019-2024)
    Table 63. Global Ponatinib Drugs Sales Market Share by Application (2025-2030)
    Table 64. Global Ponatinib Drugs Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Ponatinib Drugs Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Ponatinib Drugs Revenue Market Share by Application (2019-2024)
    Table 67. Global Ponatinib Drugs Revenue Market Share by Application (2025-2030)
    Table 68. Global Ponatinib Drugs Price (USD/Unit) by Application (2019-2024)
    Table 69. Global Ponatinib Drugs Price (USD/Unit) by Application (2025-2030)
    Table 70. ARIAD Pharmaceuticals Corporation Information
    Table 71. ARIAD Pharmaceuticals Description and Business Overview
    Table 72. ARIAD Pharmaceuticals Ponatinib Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 73. ARIAD Pharmaceuticals Ponatinib Drugs Product
    Table 74. ARIAD Pharmaceuticals Recent Developments/Updates
    Table 75. Key Raw Materials Lists
    Table 76. Raw Materials Key Suppliers Lists
    Table 77. Ponatinib Drugs Distributors List
    Table 78. Ponatinib Drugs Customers List
    Table 79. Ponatinib Drugs Market Trends
    Table 80. Ponatinib Drugs Market Drivers
    Table 81. Ponatinib Drugs Market Challenges
    Table 82. Ponatinib Drugs Market Restraints
    Table 83. Research Programs/Design for This Report
    Table 84. Key Data Information from Secondary Sources
    Table 85. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Ponatinib Drugs
    Figure 2. Global Ponatinib Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Ponatinib Drugs Market Share by Type in 2023 & 2030
    Figure 4. 45mg Product Picture
    Figure 5. 15mg Product Picture
    Figure 6. Global Ponatinib Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 7. Global Ponatinib Drugs Market Share by Application in 2023 & 2030
    Figure 8. CML
    Figure 9. ALL
    Figure 10. Global Ponatinib Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 11. Global Ponatinib Drugs Market Size (2019-2030) & (US$ Million)
    Figure 12. Global Ponatinib Drugs Sales (2019-2030) & (K Units)
    Figure 13. Global Ponatinib Drugs Average Price (USD/Unit) & (2019-2030)
    Figure 14. Ponatinib Drugs Report Years Considered
    Figure 15. Ponatinib Drugs Sales Share by Manufacturers in 2023
    Figure 16. Global Ponatinib Drugs Revenue Share by Manufacturers in 2023
    Figure 17. The Global 5 and 10 Largest Ponatinib Drugs Players: Market Share by Revenue in 2023
    Figure 18. Ponatinib Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 19. Global Ponatinib Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 20. North America Ponatinib Drugs Sales Market Share by Country (2019-2030)
    Figure 21. North America Ponatinib Drugs Revenue Market Share by Country (2019-2030)
    Figure 22. U.S. Ponatinib Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 23. Canada Ponatinib Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 24. Europe Ponatinib Drugs Sales Market Share by Country (2019-2030)
    Figure 25. Europe Ponatinib Drugs Revenue Market Share by Country (2019-2030)
    Figure 26. Germany Ponatinib Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 27. France Ponatinib Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 28. U.K. Ponatinib Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. Italy Ponatinib Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. Russia Ponatinib Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. Asia Pacific Ponatinib Drugs Sales Market Share by Region (2019-2030)
    Figure 32. Asia Pacific Ponatinib Drugs Revenue Market Share by Region (2019-2030)
    Figure 33. China Ponatinib Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 34. Japan Ponatinib Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. South Korea Ponatinib Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. India Ponatinib Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. Australia Ponatinib Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. Taiwan Ponatinib Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. Indonesia Ponatinib Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Thailand Ponatinib Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Malaysia Ponatinib Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Philippines Ponatinib Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Latin America Ponatinib Drugs Sales Market Share by Country (2019-2030)
    Figure 44. Latin America Ponatinib Drugs Revenue Market Share by Country (2019-2030)
    Figure 45. Mexico Ponatinib Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 46. Brazil Ponatinib Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 47. Argentina Ponatinib Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Middle East & Africa Ponatinib Drugs Sales Market Share by Country (2019-2030)
    Figure 49. Middle East & Africa Ponatinib Drugs Revenue Market Share by Country (2019-2030)
    Figure 50. Turkey Ponatinib Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 51. Saudi Arabia Ponatinib Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 52. UAE Ponatinib Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 53. Global Sales Market Share of Ponatinib Drugs by Type (2019-2030)
    Figure 54. Global Revenue Market Share of Ponatinib Drugs by Type (2019-2030)
    Figure 55. Global Ponatinib Drugs Price (USD/Unit) by Type (2019-2030)
    Figure 56. Global Sales Market Share of Ponatinib Drugs by Application (2019-2030)
    Figure 57. Global Revenue Market Share of Ponatinib Drugs by Application (2019-2030)
    Figure 58. Global Ponatinib Drugs Price (USD/Unit) by Application (2019-2030)
    Figure 59. Ponatinib Drugs Value Chain
    Figure 60. Ponatinib Drugs Production Process
    Figure 61. Channels of Distribution (Direct Vs Distribution)
    Figure 62. Distributors Profiles
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed

Description

Ponatinib Drugs is an oral drug developed by ARIAD Pharmaceuticalsfor the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome–positive (Ph+) acute lymphoblastic leukemia(ALL).

The global Ponatinib Drugs market was valued at US$ 592 million in 2023 and is anticipated to reach US$ 902.8 million by 2030, witnessing a CAGR of 6.4% during the forecast period 2024-2030.

Ongoing clinical trials and research exploring the use of ponatinib in different settings, combinations, or other types of cancer may have increased interest and demand for the drug.

Market Segmentation

Related Reports

Ponatinib Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Ponatinib Drugs is an oral drug developed by ARIAD Pharmaceuticalsfor the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome–positive (Ph+) acute lymphoblastic leukemia(ALL).
Published: 2024-01-24
Pages: 84
USD 3950.00
(Single User License)
Global Ponatinib Drugs Market Insights, Forecast to 2030
Ponatinib Drugs is an oral drug developed by ARIAD Pharmaceuticalsfor the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome–positive (Ph+) acute lymphoblastic leukemia(ALL).
Published: 2024-04-12
Pages: 79
USD 4900.00
(Single User License)
Global Ponatinib Drugs Market Research Report 2025
The global market for Ponatinib Drugs was valued at US$ 660 million in the year 2024 and is projected to reach a revised size of US$ 1009 million by 2031, growing at a CAGR of 6.4% during the forecast period.
Published: 2025-02-25
Pages: 70
USD 2900.00
(Single User License)
Ponatinib Drugs- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Ponatinib Drugs was estimated to be worth US$ 660 million in 2024 and is forecast to a readjusted size of US$ 1009 million by 2031 with a CAGR of 6.4% during the forecast period 2025-2031.
Published: 2025-02-25
Pages: 90
USD 3950.00
(Single User License)
Global Ponatinib Drugs Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Ponatinib Drugs market size was US$ 660 million in 2024 and is forecast to a readjusted size of US$ 1009 million by 2031 with a CAGR of 6.4% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 72
USD 4250.00
(Single User License)
Global Ponatinib Drugs Market Research Report 2026
The global Ponatinib Drugs market was valued at US$ 697 million in 2025 and is anticipated to reach US$ 1067 million by 2032, at a CAGR of 6.4% from 2026 to 2032.
Published: 2026-04-27
Pages: 99
USD 2900.00
(Single User License)

Ponatinib Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Ponatinib Drugs is an oral drug developed by ARIAD Pharmaceuticalsfor the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome–positive (Ph+) acute lymphoblastic leukemia(ALL).
Published: 2024-01-24
Pages: 84
USD 3950.00 ()
Global Ponatinib Drugs Market Insights, Forecast to 2030
Ponatinib Drugs is an oral drug developed by ARIAD Pharmaceuticalsfor the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome–positive (Ph+) acute lymphoblastic leukemia(ALL).
Published: 2024-04-12
Pages: 79
USD 4900.00 ()
Global Ponatinib Drugs Market Research Report 2025
The global market for Ponatinib Drugs was valued at US$ 660 million in the year 2024 and is projected to reach a revised size of US$ 1009 million by 2031, growing at a CAGR of 6.4% during the forecast period.
Published: 2025-02-25
Pages: 70
USD 2900.00 ()
Ponatinib Drugs- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Ponatinib Drugs was estimated to be worth US$ 660 million in 2024 and is forecast to a readjusted size of US$ 1009 million by 2031 with a CAGR of 6.4% during the forecast period 2025-2031.
Published: 2025-02-25
Pages: 90
USD 3950.00 ()
Global Ponatinib Drugs Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Ponatinib Drugs market size was US$ 660 million in 2024 and is forecast to a readjusted size of US$ 1009 million by 2031 with a CAGR of 6.4% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 72
USD 4250.00 ()
Global Ponatinib Drugs Market Research Report 2026
The global Ponatinib Drugs market was valued at US$ 697 million in 2025 and is anticipated to reach US$ 1067 million by 2032, at a CAGR of 6.4% from 2026 to 2032.
Published: 2026-04-27
Pages: 99
USD 2900.00 ()